These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 791667)

  • 21. Macrophage accumulation, division, maturation, and digestive and microbicidal capacities in tuberculous lesions. I. Studies involving their incorporation of tritiated thymidine and their content of lysosomal enzymes and bacilli.
    Shima K; Dannenberg AM; Ando M; Chandrasekhar S; Seluzicki JA; Fabrikant JI
    Am J Pathol; 1972 Apr; 67(1):159-80. PubMed ID: 4558220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunocytochemical demonstration of rabbit ribonuclease and phospholipase A2 by the peroxidase-antiperoxidase technique in professional phagocytes (pulmonary alveolar macrophages and granulocytic and mononuclear peritoneal exudate cells) and in glycol methacrylate sections of dermal tuberculous (BCG) lesions.
    Namba M; Suga M; Tanaka F; Dannenberg AM; Hastie AT; Franson RC
    J Reticuloendothel Soc; 1983 Dec; 34(6):425-35. PubMed ID: 6361253
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiplex PCR-identified cutaneous tuberculosis evoked by Mycobacterium bovis BCG vaccination in a healthy baby.
    Okazaki T; Ebihara S; Takahashi H; Asada M; Sato A; Seki M; Ohto H; Sasaki H
    J Clin Microbiol; 2005 Jan; 43(1):523-5. PubMed ID: 15635035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG.
    Dannenberg AM
    Tuberculosis (Edinb); 2003; 83(4):251-60. PubMed ID: 12906836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of MBL-associated serine protease-2 (MASP-2) on liquefaction and ulceration in rabbit skin model of tuberculosis.
    Dong X; Luo Y; Gao Q; Lu X; Wang Q; Zhang Y; Liu X; Zhang L; Wang J; Ma X; Zhu B
    Microb Pathog; 2016 Oct; 99():282-286. PubMed ID: 27585546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Calciferol therapy of tuberculosis verrucosa cutis at site of BCG vaccination].
    HALBERG V
    Ugeskr Laeger; 1953 Jun; 115(26):1032-3. PubMed ID: 13090388
    [No Abstract]   [Full Text] [Related]  

  • 27. BCG skin infection.
    Roilides EJ; Vanioti-Papasava G
    Pediatr Infect Dis; 1986; 5(1):110. PubMed ID: 3511453
    [No Abstract]   [Full Text] [Related]  

  • 28. [Development of so-called cutaneous tuberculosis by BCG vaccination].
    GEHRELS PE
    Z Haut Geschlechtskr; 1956 Apr; 20(8):228-37. PubMed ID: 13325681
    [No Abstract]   [Full Text] [Related]  

  • 29. [COMPARISON OF BCG VACCINES PRODUCED IN POLAND WITH BCG VACCINES PREPARED FROM BCG SUBSTRAINS OF VARIOUS ORIGINS].
    BURACZEWSKA M; KURYLOWICZ W; PAKLERSKA-POBRATYN H
    Gruzlica (1926); 1964 Sep; 32():781-8. PubMed ID: 14249995
    [No Abstract]   [Full Text] [Related]  

  • 30. [Desensitization with BCG in a case of Bazin's erythema induratum].
    BAPTISTA L; BECHELLI LM; ALAYON FL
    Rev Paul Med; 1952 Feb; 40(2):127-34. PubMed ID: 14949695
    [No Abstract]   [Full Text] [Related]  

  • 31. Papular tuberculids post-BCG vaccination.
    Figueiredo A; Poiares-Baptista A; Branco M; da Mota HC
    Int J Dermatol; 1987 Jun; 26(5):291-4. PubMed ID: 3610434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MECHANISM OF TUBERCULOSIS IMMUNITY WITH SPECIAL REFERENCE TO CELLULAR FACTORS.
    TSUJI S
    Acta Tuberc Jpn; 1964 Mar; 13():41-53. PubMed ID: 14153263
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous malakoplakia: a report of two cases with the use of anti-BCG for the detection for micro-organisms.
    Mehregan DR; Mehregan AH; Mehregan DA
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):351-4. PubMed ID: 10901721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scrofuloderma appearing in the regional lymph nodes after BCG vaccination].
    CAJGFINGER H; COLOMD D
    Lyon Med; 1956 Jul; 88(29):57-8. PubMed ID: 13368616
    [No Abstract]   [Full Text] [Related]  

  • 35. Results of oral B.C.G. vaccination administered in repeated doses at intervals to patients with cutaneous tuberculosis and similar diseases.
    BAPTISTA L; BELLIBONI N
    Dermatologica; 1955 Feb; 110(2):132-43. PubMed ID: 14379761
    [No Abstract]   [Full Text] [Related]  

  • 36. [PRIMARY CUTANEOUS TUBERCULOSIS].
    MERLET L; GORENA M
    Rev Chil Pediatr; 1963 Nov; 34():853-4. PubMed ID: 14124384
    [No Abstract]   [Full Text] [Related]  

  • 37. HISTOPATHOLOGIC STUDIES AFTER BOOSTER EXPERIMENTS WITH PPD IN EXPERIMENTAL TUBERCULOUS INFECTION.
    DAHLSTROEM G; FAGRAEUS A
    Acta Tuberc Pneumol Scand Suppl; 1964; 56():SUPPL 56:118+. PubMed ID: 14162299
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of blockade and stimulation of the reticulo-endothelial system on the development of experimental tuberculosis. A histochemical study. II. Studies on Mycobacterium tuberculosis (BCG).
    Kotz J
    Folia Histochem Cytochem (Krakow); 1968; 6(3):405-31. PubMed ID: 4878422
    [No Abstract]   [Full Text] [Related]  

  • 39. Two infants with tuberculid associated with Kawasaki disease.
    Yamada H; Ohta H; Hasegawa S; Azuma Y; Hasegawa M; Kadoya R; Ohbuchi N; Ohnishi Y; Okada S; Hoshide M; Ohga S
    Hum Vaccin Immunother; 2016 Nov; 12(11):2772-2776. PubMed ID: 27435523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disseminated Erythematous Papules and Pustules: A Quiz.
    Fujita Y; Shiiya C; Inamura-Takashima Y; Nomura T; Shibaki A; Shimizu H
    Acta Derm Venereol; 2019 Jan; 99(1):123-124. PubMed ID: 30176041
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.